NIH #5U01AG073323-05
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery
Expiring Soon
- Amount
- $781K
- Period
- 2021-09-01 → 2026-08-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #1OT2OD038083-01
HF-ETIOLOGY: Heart Failure Endotypes from Ethical, Multi-Modal AI driven and Molecular/Phenotypic Data Integration Enabled Discovery
Expiring Soon
- Amount
- $1.7M
- Period
- 2025-09-01 → 2026-08-31
- PIs
- 4
- Est. capacity / PI
- ~1 students
Awarded at NORTHWESTERN UNIVERSITY
NIH #5U01AG073323-04
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery
Expiring Soon
- Amount
- $797K
- Period
- 2021-09-01 → 2026-08-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #5U01AG073323-03
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery
Expiring Soon
- Amount
- $797K
- Period
- 2021-09-01 → 2026-08-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #5U01AG073323-02
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery
Expiring Soon
- Amount
- $797K
- Period
- 2021-09-01 → 2026-08-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #1U01AG073323-01
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery
Expiring Soon
- Amount
- $797K
- Period
- 2021-09-01 → 2026-08-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #1RF1NS133812-01
Dark GPCR signaling underlying the Microbiome-Gut-Brain Axis for Alzheimer's Disease and Related Dementia
Expiring Soon
- Amount
- $2.3M
- Period
- 2023-08-18 → 2026-07-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #5R01AG092462-02
Mapping proteomic changes of tauopathy in human neurons
Active
- Amount
- $682K
- Period
- 2025-06-01 → 2030-03-31
- PIs
- 3
- Est. capacity / PI
- ~2 students
Awarded at WEILL MEDICAL COLL OF CORNELL UNIV
NIH #1R01AG092462-01
Mapping proteomic changes of tauopathy in human neurons
Active
- Amount
- $718K
- Period
- 2025-06-01 → 2030-03-31
- PIs
- 3
- Est. capacity / PI
- ~3 students
Awarded at WEILL MEDICAL COLL OF CORNELL UNIV
NIH #5R01AG092591-02
A Multimodal, Multiscale and Multistage Systems Biology (M3SB) Infrastructure for Precision Medicine in Alzheimer’s Disease and Longevity
Active
- Amount
- $787K
- Period
- 2025-06-01 → 2030-02-28
- PIs
- 3
- Est. capacity / PI
- ~3 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #1R01AG092591-01
A Multimodal, Multiscale and Multistage Systems Biology (M3SB) Infrastructure for Precision Medicine in Alzheimer’s Disease and Longevity
Active
- Amount
- $802K
- Period
- 2025-06-01 → 2030-02-28
- PIs
- 3
- Est. capacity / PI
- ~3 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #4R33AG083003-02
Precision Medicine Digital Twins for Alzheimer’s Target and Drug Discovery and Longevity
Active
- Amount
- $552K
- Period
- 2023-08-15 → 2028-08-31
- PIs
- 1
- Est. capacity / PI
- ~3 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #1U01CA294154-01A1
Deep learning based 3D network biology knowledge portal for precision oncology
Active
- Amount
- $414K
- Period
- 2025-08-04 → 2028-07-31
- PIs
- 2
- Est. capacity / PI
- ~2 students
Awarded at CORNELL UNIVERSITY
NIH #5R01AG082118-03
Characterize neuronal and glial cell-specific vulnerability to proteinopathies in Alzheimer's disease using multimodal single-nuclei genomic and epigenomic approaches
Active
- Amount
- $783K
- Period
- 2023-09-01 → 2028-05-31
- PIs
- 4
- Est. capacity / PI
- ~1 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #5R01AG082118-02
Characterize neuronal and glial cell-specific vulnerability to proteinopathies in Alzheimer's disease using multimodal single-nuclei genomic and epigenomic approaches
Active
- Amount
- $796K
- Period
- 2023-09-01 → 2028-05-31
- PIs
- 4
- Est. capacity / PI
- ~1 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #1R01AG082118-01
Characterize neuronal and glial cell-specific vulnerability to proteinopathies in Alzheimer's disease using multimodal single-nuclei genomic and epigenomic approaches
Active
- Amount
- $812K
- Period
- 2023-09-01 → 2028-05-31
- PIs
- 4
- Est. capacity / PI
- ~1 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #4R01AG082211-02
Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing
Active
- Amount
- $781K
- Period
- 2023-05-15 → 2028-04-30
- PIs
- 3
- Est. capacity / PI
- ~1 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #5R01AG084250-04
Microglial Activation and Inflammatory Endophenotypes Underlying Sex Differences of Alzheimer’s Disease
Active
- Amount
- $549K
- Period
- 2023-09-22 → 2027-05-31
- PIs
- 2
- Est. capacity / PI
- ~1 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #5R01AG084250-03
Microglial Activation and Inflammatory Endophenotypes Underlying Sex Differences of Alzheimer’s Disease
Active
- Amount
- $538K
- Period
- 2023-09-22 → 2027-05-31
- PIs
- 2
- Est. capacity / PI
- ~1 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #5R01AG084250-02
Microglial Activation and Inflammatory Endophenotypes Underlying Sex Differences of Alzheimer’s Disease
Active
- Amount
- $561K
- Period
- 2023-09-22 → 2027-05-31
- PIs
- 2
- Est. capacity / PI
- ~1 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #1R01AG084250-01
Microglial Activation and Inflammatory Endophenotypes Underlying Sex Differences of Alzheimer’s Disease
Active
- Amount
- $558K
- Period
- 2023-09-22 → 2027-05-31
- PIs
- 2
- Est. capacity / PI
- ~1 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #5R01AG076448-05
TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimers Disease
Active
- Amount
- $794K
- Period
- 2022-07-15 → 2027-03-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #5R01AG076448-04
TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimers Disease
Active
- Amount
- $781K
- Period
- 2022-07-15 → 2027-03-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #5R01AG076448-03
TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimers Disease
Active
- Amount
- $810K
- Period
- 2022-07-15 → 2027-03-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #5R01AG076448-02
TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimers Disease
Active
- Amount
- $817K
- Period
- 2022-07-15 → 2027-03-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #1R01AG076448-01
TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimers Disease
Active
- Amount
- $832K
- Period
- 2022-07-15 → 2027-03-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #1RF1AG082211-01
Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing
- Amount
- $2.4M
- Period
- 2023-05-15 → 2026-04-30
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #5R01AG066707-05
Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimers Disease
- Amount
- $592K
- Period
- 2020-04-15 → 2025-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #1R21AG083003-01
Precision Medicine Digital Twins for Alzheimer’s Target and Drug Discovery and Longevity
- Amount
- $483K
- Period
- 2023-08-15 → 2025-08-14
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #5R01AG066707-04
Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimers Disease
- Amount
- $722K
- Period
- 2020-04-15 → 2024-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #5R01AG066707-03
Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimers Disease
- Amount
- $771K
- Period
- 2020-04-15 → 2024-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #3R01AG066707-02S1
Endophenotype Network-based Approaches to Prediction and Population-based Validation of In Silico Drug Repurposing for Alzheimer's Disease
- Amount
- $322K
- Period
- 2020-04-15 → 2024-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #5R01AG066707-02
Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimers Disease
- Amount
- $664K
- Period
- 2020-04-15 → 2024-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #1R01AG066707-01
Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimers Disease
- Amount
- $635K
- Period
- 2020-04-15 → 2024-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #3R01AG066707-01S1
Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimer's Disease
- Amount
- $396K
- Period
- 2020-04-15 → 2024-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #1R56AG074001-01
Multimodal single-cell genomic and epigenomic analyses elucidate Alzheimer’s sexual dimorphism in human immune systems aging
- Amount
- $1.2M
- Period
- 2021-09-05 → 2023-08-31
- PIs
- 4
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #5R00HL138272-04
An individualized network medicine infrastructure for precision cardio-oncology
- Amount
- $249K
- Period
- 2017-07-01 → 2022-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #5R00HL138272-03
An individualized network medicine infrastructure for precision cardio-oncology
- Amount
- $249K
- Period
- 2017-07-01 → 2021-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #4R00HL138272-02
An individualized network medicine infrastructure for precision cardio-oncology
- Amount
- $249K
- Period
- 2017-07-01 → 2021-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #1K99HL138272-01
An individualized network medicine infrastructure for precision cardio-oncology
- Amount
- $86K
- Period
- 2017-07-01 → 2018-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at NORTHEASTERN UNIVERSITY